Dagnamyelew Tilahun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dagnamyelew Tilahun has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alqeer Aliyo
Bule Hora University
1 shared publication Aster Tsegaye
Department of Medical Laboratory Sciences, Addis Ababa University, Addis Ababa, Ethiopia
1 shared publication- Degefa Dhengesu
Bule Hora University
1 shared publication - Deresse Daka
Hawassa University College of Medicine and Health Sciences, Hawassa, Ethiopia
1 shared publication - Girma Ashenafi
Bule Hora University
1 shared publication Hailu Lemma
Department of Environmental Health, Institute of Health, Bule Hora University, Bule Hora Town, Oromia, Ethiopia
1 shared publication
Latest Publications
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 14, 543-554
Immunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia
Background: Immunohematological abnormalities among human immunodeficiency virus-infected patients are common abnormalities associated with severe depletion of the immune system, covering a stage of acute syndrome to an advanced disease. The greatest impact was observed in the low- and middle-income countries. However, in Ethiopia, little attention has been paid, and only limited published information exists regarding immunohematological abnormalities among individuals receiving highly active antiretroviral treatment. Objective: This study aimed to assess changes in immunological and hematological parameters in HIV-infected patients receiving HAART for at least six months at the antiretroviral therapy clinic of Yabelo Hospital, Borena, Ethiopia. Methods: A cross-sectional study was conducted from February to July 2021 using convenient sampling to recruit 333 participants. Sociodemographic data and clinical characteristics were collected using a pretested questionnaire. Baseline data were extracted from medical records and after six month immunohematological measurements were performed on blood samples collected during the study period. Data analysis was performed using SPSS version 25. Descriptive analysis was performed, and the results are presented as numbers and percentages or means ± SD. A paired t-test was used to compare the mean values of the immunohematological parameters before and after six of taking HAART. Statistical significance was set at P < 0.05. Results: The prevalence of anemia, leucopenia, neutropenia, lymphopenia and thrombocytopenia were 47.4%, 73.3%, 58.3%, 76.9% and 3.3% before initiation of HAART and 23.1%, 36.4%, 23.4%, 35.7% and 2.4% after initiation of HAART, respectively; Compared to baseline, there was also a significant decrease in the rate of Immunosuppression (CD4 < 350) from 62.2% at base line to 20.7% after HAART initiation. Conclusion: Immunohematological profile of the patients improved after the initiation of HAART. The observation of large proportion of immunosuppressed individuals at baseline warrants advocating for HIV testing in the pastoralist community so that infected patients could benefit from early initiation of HAART.
- 1 October 2023
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 14, 543-554
Open AccessImmunohematological Outcome Among Adult HIV Patients Taking Highly Active Antiretroviral Therapy for at Least Six Months in Yabelo Hospital, Borana, Ethiopia
Background: Immunohematological abnormalities among human immunodeficiency virus-infected patients are common abnormalities associated with severe depletion of the immune system, covering a stage of acute syndrome to an advanced disease. The greatest impact was observed in the low- and middle-income countries. However, in Ethiopia, little attention has been paid, and only limited published information exists regarding immunohematological abnormalities among individuals receiving highly active antiretroviral treatment. Objective: This study aimed to assess changes in immunological and hematological parameters in HIV-infected patients receiving HAART for at least six months at the antiretroviral therapy clinic of Yabelo Hospital, Borena, Ethiopia. Methods: A cross-sectional study was conducted from February to July 2021 using convenient sampling to recruit 333 participants. Sociodemographic data and clinical characteristics were collected using a pretested questionnaire. Baseline data were extracted from medical records and after six month immunohematological measurements were performed on blood samples collected during the study period. Data analysis was performed using SPSS version 25. Descriptive analysis was performed, and the results are presented as numbers and percentages or means ± SD. A paired t-test was used to compare the mean values of the immunohematological parameters before and after six of taking HAART. Statistical significance was set at P < 0.05. Results: The prevalence of anemia, leucopenia, neutropenia, lymphopenia and thrombocytopenia were 47.4%, 73.3%, 58.3%, 76.9% and 3.3% before initiation of HAART and 23.1%, 36.4%, 23.4%, 35.7% and 2.4% after initiation of HAART, respectively; Compared to baseline, there was also a significant decrease in the rate of Immunosuppression (CD4 < 350) from 62.2% at base line to 20.7% after HAART initiation. Conclusion: Immunohematological profile of the patients improved after the initiation of HAART. The observation of large proportion of immunosuppressed individuals at baseline warrants advocating for HIV testing in the pastoralist community so that infected patients could benefit from early initiation of HAART.
- Open Access
- 6 July 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 4421-4433
Prevalence, Antimicrobial Susceptibility Pattern and Associated Factors of Group B Streptococcus Among Pregnant Women Attending Antenatal Care at Bule Hora University Teaching Hospital, Southern Ethiopia
Background: In many parts of the world, Group B Streptococcus (GBS) is a major cause of maternal and neonatal illness and mortality. It has a negative impact on neonatal and pregnancy outcomes. A worrisome problem in Ethiopia is the unknown rate of antibiotic resistance and the risk factors connected to GBS infections. Objective: This study was to determine the prevalence, antibiotic susceptibility pattern, and related variables of Group B Streptococcus among pregnant women receiving prenatal treatment conducted at Bule Hora University Teaching Hospital, Southern Ethiopia, between June 1 and August 30, 2022. Methods: An institutional-based cross-sectional study was conducted among 213 pregnant women attending antenatal care at Bule Hora University Teaching Hospital. Data on sociodemographic and related factors were gathered using structured questionnaires. The study’s participants were selected using the consecutive sampling method. The lower vaginal/rectum area was brushed with a sterile cotton swab to capture the vaginal/rectum swab sample, which was then examined using microbiological techniques. The Kirby-Bauer disc diffusion method was used to assess antibiotic susceptibility in GBS isolates. Logistic regression analysis was performed on the data using SPSS version 26. It was deemed statistically significant when the p-value was 0.05 with a 95% confidence interval (CI). Results: The overall prevalence of GBS was 16.9% (CI: 0.12– 0.23). A history of prematurity of the membrane (AOR: 3.35, 95% CI: 1.19– 9.45), a history of stillbirth (AOR: 2.88, 95% CI: 1.07– 7.71), and preterm delivery history (AOR: 3.41, 95% CI: 1.31– 8.89) (p 0.05) were independent predictors of GBS infection. Cefepime had the highest resistance at 58.3%. Most GBS isolates showed high susceptibility to vancomycin (97.2%) and ampicillin (91.7%). Multidrug resistance was 13.9%. Conclusion: The prevalence of GBS was considerably high among pregnant women in this study. This finding emphasises the need for routine screening and testing of antimicrobial susceptibility to provide antibiotic prophylaxis and minimise newborn infection and comorbidity.
- 6 July 2023
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 4421-4433
Open AccessPrevalence, Antimicrobial Susceptibility Pattern and Associated Factors of Group B Streptococcus Among Pregnant Women Attending Antenatal Care at Bule Hora University Teaching Hospital, Southern Ethiopia
Background: In many parts of the world, Group B Streptococcus (GBS) is a major cause of maternal and neonatal illness and mortality. It has a negative impact on neonatal and pregnancy outcomes. A worrisome problem in Ethiopia is the unknown rate of antibiotic resistance and the risk factors connected to GBS infections. Objective: This study was to determine the prevalence, antibiotic susceptibility pattern, and related variables of Group B Streptococcus among pregnant women receiving prenatal treatment conducted at Bule Hora University Teaching Hospital, Southern Ethiopia, between June 1 and August 30, 2022. Methods: An institutional-based cross-sectional study was conducted among 213 pregnant women attending antenatal care at Bule Hora University Teaching Hospital. Data on sociodemographic and related factors were gathered using structured questionnaires. The study’s participants were selected using the consecutive sampling method. The lower vaginal/rectum area was brushed with a sterile cotton swab to capture the vaginal/rectum swab sample, which was then examined using microbiological techniques. The Kirby-Bauer disc diffusion method was used to assess antibiotic susceptibility in GBS isolates. Logistic regression analysis was performed on the data using SPSS version 26. It was deemed statistically significant when the p-value was 0.05 with a 95% confidence interval (CI). Results: The overall prevalence of GBS was 16.9% (CI: 0.12– 0.23). A history of prematurity of the membrane (AOR: 3.35, 95% CI: 1.19– 9.45), a history of stillbirth (AOR: 2.88, 95% CI: 1.07– 7.71), and preterm delivery history (AOR: 3.41, 95% CI: 1.31– 8.89) (p 0.05) were independent predictors of GBS infection. Cefepime had the highest resistance at 58.3%. Most GBS isolates showed high susceptibility to vancomycin (97.2%) and ampicillin (91.7%). Multidrug resistance was 13.9%. Conclusion: The prevalence of GBS was considerably high among pregnant women in this study. This finding emphasises the need for routine screening and testing of antimicrobial susceptibility to provide antibiotic prophylaxis and minimise newborn infection and comorbidity.
- Open Access
- 25 August 2022
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 15, 1569-1580
Antimicrobial Resistance Profile of Enterobacteriaceae and Drinking Water Quality Among Households in Bule Hora Town, South Ethiopia
Background: Antimicrobial resistance bacteria and unsafe water are contributing to the growing burden of diseases. Hence, isolation and antimicrobial susceptibility tests for drinking water samples are currently becoming vital to address the human health risks from drinking unsafe water. Objective: This study aimed to assess the antimicrobial resistance profile of Enterobacteriaceae and quality of drinking water among households in Bule Hora Town, South Ethiopia. Methods and Materials: A community-based cross-sectional study was used from June to August 2021. A total of 75 water samples were collected and analyzed at the Microbiological Laboratory of Bule Hora University within 6 hours. A membrane filtration method and biochemical tests were used for the isolation and identification of bacteria. An antimicrobial susceptibility test was performed using Kirby–Bauer disc-diffusion method on Mueller–Hinton Agar. Systematic and simple random probability sampling techniques were used to draw representative samples. The data were entered into Epi Data 3.1 and then exported to SPSS version 25 where univariate and bivariate analyses of the data were conducted. Results: This study indicated that 59 (78.6%), 30 (40%), and 20 (26.6%) of water samples from the storage of households were contaminated with total coliforms, thermo-tolerant coliforms, and Escherichia coli, respectively. Similarly, Salmonella accounted for 18 (24%), Shigella 12 (16%), and other members of the Enterobacteriaceae such as Proteus, Citrobacter, Klebsiella, Escherichia coli, and Enterobacter species were also isolated. All isolates of Enterobacteriaceae showed resistance to amoxicillin plus clavulanic acid and ampicillin. Besides, Shigella showed 10 (83.3%), 2 (16.6%) and 10 (83.3%) and Salmonella showed 16 (88.9%), 5 (27.8%) and 15 (83.3%) resistant to cotrimoxazole, chloramphenicol and tetracycline, respectively. All the tested drinking water samples had no free chlorine at all at point of use. Conclusion: There was contamination of drinking water with coliform and antibiotic-resistant Enterobacteriaceae in most surveyed households.
- 25 August 2022
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 15, 1569-1580
Open AccessAntimicrobial Resistance Profile of Enterobacteriaceae and Drinking Water Quality Among Households in Bule Hora Town, South Ethiopia
Background: Antimicrobial resistance bacteria and unsafe water are contributing to the growing burden of diseases. Hence, isolation and antimicrobial susceptibility tests for drinking water samples are currently becoming vital to address the human health risks from drinking unsafe water. Objective: This study aimed to assess the antimicrobial resistance profile of Enterobacteriaceae and quality of drinking water among households in Bule Hora Town, South Ethiopia. Methods and Materials: A community-based cross-sectional study was used from June to August 2021. A total of 75 water samples were collected and analyzed at the Microbiological Laboratory of Bule Hora University within 6 hours. A membrane filtration method and biochemical tests were used for the isolation and identification of bacteria. An antimicrobial susceptibility test was performed using Kirby–Bauer disc-diffusion method on Mueller–Hinton Agar. Systematic and simple random probability sampling techniques were used to draw representative samples. The data were entered into Epi Data 3.1 and then exported to SPSS version 25 where univariate and bivariate analyses of the data were conducted. Results: This study indicated that 59 (78.6%), 30 (40%), and 20 (26.6%) of water samples from the storage of households were contaminated with total coliforms, thermo-tolerant coliforms, and Escherichia coli, respectively. Similarly, Salmonella accounted for 18 (24%), Shigella 12 (16%), and other members of the Enterobacteriaceae such as Proteus, Citrobacter, Klebsiella, Escherichia coli, and Enterobacter species were also isolated. All isolates of Enterobacteriaceae showed resistance to amoxicillin plus clavulanic acid and ampicillin. Besides, Shigella showed 10 (83.3%), 2 (16.6%) and 10 (83.3%) and Salmonella showed 16 (88.9%), 5 (27.8%) and 15 (83.3%) resistant to cotrimoxazole, chloramphenicol and tetracycline, respectively. All the tested drinking water samples had no free chlorine at all at point of use. Conclusion: There was contamination of drinking water with coliform and antibiotic-resistant Enterobacteriaceae in most surveyed households.